Danske Bank’s Roivant Sciences ROIV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$10.6K Hold
300
﹤0.01% 809
2026
Q1
$8.31K Sell
300
-8,800
-97% -$226K ﹤0.01% 832
2025
Q4
$197K Hold
9,100
﹤0.01% 678
2025
Q3
$138K Hold
9,100
﹤0.01% 814
2025
Q2
$103K Buy
9,100
+8,400
+1,200% +$91K ﹤0.01% 844
2025
Q1
$7.06K Hold
700
﹤0.01% 1134
2024
Q4
$8.28K Sell
700
-4,500
-87% -$53.2K ﹤0.01% 1134
2024
Q3
$60K Buy
+5,200
New +$59.2K ﹤0.01% 1155

Other funds holding ROIV

Danske Bank's ROIV Position: Q2 2026 in Review

Danske Bank held its Roivant Sciences (ROIV) position steady in Q2 2026 at 300 shares worth $10.6K. The position accounts for ﹤0.01% of the portfolio, ranked #809.

Danske Bank first reported a position in ROIV in Q3 2024 and has held it in 8 quarters since. The position peaked at $197K in Q4 2025. 391 funds tracked by Wall St. Rank hold ROIV as of Q2 2026.

  • Danske Bank held 300 shares of Roivant Sciences worth $10.6K as of Q2 2026.
  • Danske Bank left its Roivant Sciences share count unchanged in Q2 2026.
  • Roivant Sciences made up ﹤0.01% of Danske Bank's portfolio in Q2 2026, its #809 holding.
  • Danske Bank first reported a position in Roivant Sciences in Q3 2024 and has held it in 8 quarters since.
  • Danske Bank's Roivant Sciences position peaked at $197K in Q4 2025.
  • 391 funds tracked by Wall St. Rank held Roivant Sciences as of Q2 2026.

Based on Danske Bank's 13F filing for Q2 2026, filed 10 Aug 2026.